Spots Global Cancer Trial Database for therapeutic hydrocortisone

Every month we try and update this database with for therapeutic hydrocortisone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia	NCT00002785	Leukemia	filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine mesna methotrexate methylprednisol... pegaspargase prednisone therapeutic hyd... vincristine sul... allogeneic bone... low-LET cobalt-... low-LET photon ...	- 1 Year	Children's Oncology Group
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	NCT00049569	L1 Childhood Ac... L2 Childhood Ac... Non-T, Non-B Ch... Recurrent Child... T-cell Childhoo...	cytarabine methotrexate vincristine sul... prednisone pegaspargase doxorubicin hyd... imatinib mesyla... cyclophosphamid... etoposide filgrastim leucovorin calc... asparaginase therapeutic hyd...	1 Year - 21 Years	National Cancer Institute (NCI)
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy	NCT00559481	Prostate Cancer	dexamethasone ketoconazole therapeutic hyd... pharmacological...	-	Roswell Park Cancer Institute
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002756	Leukemia	filgrastim asparaginase cyclophosphamid... cytarabine daunorubicin hy... etoposide leucovorin calc... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul...	- 1 Year	Children's Oncology Group
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia	NCT02101853	Recurrent B Acu...	Allogeneic Hema... Asparaginase Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Etoposide Leucovorin Calc... Mercaptopurine Methotrexate Mitoxantrone Mitoxantrone Hy... Pegaspargase Pharmacological... Radiation Thera... Therapeutic Hyd... Thioguanine Vincristine Vincristine Sul...	1 Year - 31 Years	National Cancer Institute (NCI)
Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy	NCT00309894	Prostate Cancer	sargramostim ketoconazole therapeutic hyd...	- 120 Years	University of California, San Francisco
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002744	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase prednisone therapeutic hyd... thioguanine vincristine sul... low-LET cobalt-... low-LET photon ...	1 Year - 9 Years	Children's Oncology Group
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy	NCT00559481	Prostate Cancer	dexamethasone ketoconazole therapeutic hyd... pharmacological...	-	Roswell Park Cancer Institute
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia	NCT00550992	Leukemia	anti-thymocyte ... asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide leucovorin calc... melphalan mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisolone prednisone therapeutic hyd... thioguanine vincristine sul... allogeneic bone... allogeneic hema... umbilical cord ...	- 1 Year	Dutch Childhood Oncology Group
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma	NCT01700946	Recurrent B-Cel... Recurrent Child...	dexamethasone vincristine sul... rituximab clofarabine cyclophosphamid... etoposide aldesleukin pegaspargase methotrexate mercaptopurine cytarabine mitoxantrone teniposide vinblastine natural killer ... laboratory biom... therapeutic hyd... allogeneic hema... CliniMACS	- 21 Years	St. Jude Children's Research Hospital
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab	NCT01867294	Advanced Malign... Dermatologic Co...	Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd...	18 Years -	Academic and Community Cancer Research United
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia	NCT00002704	Leukemia	filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ...	- 20 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia	NCT00002494	Leukemia Lymphoma	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mesna methotrexate prednisone therapeutic hyd... vincristine sul... low-LET cobalt-... low-LET photon ...	15 Years -	Alliance for Clinical Trials in Oncology
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia	NCT00002704	Leukemia	filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ...	- 20 Years	National Cancer Institute (NCI)
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome	NCT03813147	Acute Myeloid L... Recurrent Acute... Recurrent Myelo... Refractory Acut... Refractory Myel...	Azacitidine Cytarabine Fludarabine Pho... Methotrexate Pevonedistat Therapeutic Hyd...	1 Month - 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002744	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase prednisone therapeutic hyd... thioguanine vincristine sul... low-LET cobalt-... low-LET photon ...	1 Year - 9 Years	Children's Oncology Group
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy	NCT00559481	Prostate Cancer	dexamethasone ketoconazole therapeutic hyd... pharmacological...	-	Roswell Park Cancer Institute
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma	NCT00002757	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul...	- 20 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma	NCT00002471	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... methotrexate methylprednisol... therapeutic hyd... thiotepa vincristine sul...	-	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma	NCT01230983	Cardiac Toxicit... Leukemia Lymphoma	asparaginase cytarabine dexrazoxane hyd... doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul... radiation thera...	- 21 Years	Children's Oncology Group
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia	NCT00003436	Leukemia Myelodysplastic...	amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone...	- 15 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00557193	Acute Lymphobla... Acute Undiffere... Childhood T Acu...	Asparaginase Biospecimen Col... Bone Marrow Bio... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Echocardiograph... Etoposide Filgrastim Laboratory Biom... Lestaurtinib Leucovorin Calc... Mercaptopurine Methotrexate Methylprednisol... Multigated Acqu... Pegaspargase Pharmacological... Prednisone Therapeutic Hyd... Vincristine Sul...	- 1 Year	Children's Oncology Group
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes	NCT00096135	Leukemia	filgrastim cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine methotrexate pegaspargase therapeutic hyd... vincristine sul... radiation thera...	18 Months - 29 Years	Children's Oncology Group
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab	NCT01867294	Advanced Malign... Dermatologic Co...	Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd...	18 Years -	Academic and Community Cancer Research United
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome	NCT00002798	Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... Chronic Myelomo... de Novo Myelody... Refractory Anem... Refractory Anem... Refractory Anem... Refractory Anem... Secondary Myelo... Untreated Child...	asparaginase daunorubicin hy... fludarabine pho... therapeutic hyd... allogeneic bone... 3-dimensional c... filgrastim cytarabine idarubicin dexamethasone thioguanine etoposide methotrexate cyclophosphamid... aldesleukin busulfan	- 21 Years	National Cancer Institute (NCI)
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)	NCT00098839	Recurrent Child...	L-asparaginase doxorubicin hyd... therapeutic hyd... vincristine sul... epratuzumab cytarabine prednisone pegaspargase dexrazoxane hyd... methotrexate etoposide cyclophosphamid... leucovorin calc... filgrastim	2 Years - 31 Years	Children's Oncology Group
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes	NCT00096135	Leukemia	filgrastim cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine methotrexate pegaspargase therapeutic hyd... vincristine sul... radiation thera...	18 Months - 29 Years	Children's Oncology Group
506U78 in Treating Patients With Refractory Hematologic Cancer	NCT00002970	Recurrent Child... Recurrent Child... T-cell Childhoo...	nelarabine methotrexate cytarabine therapeutic hyd...	- 21 Years	National Cancer Institute (NCI)
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT00873093	B-cell Adult Ac... B-cell Childhoo... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... T-cell Adult Ac... T-cell Childhoo...	L-asparaginase doxorubicin hyd... therapeutic hyd... vincristine sul... cytarabine prednisone bortezomib pegaspargase methotrexate etoposide phosp... cyclophosphamid... filgrastim leucovorin calc... laboratory biom... High Dose MTX	1 Year - 31 Years	National Cancer Institute (NCI)
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy	NCT00460031	Prostate Cancer	ketoconazole lenalidomide therapeutic hyd...	18 Years -	Case Comprehensive Cancer Center
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia	NCT00002700	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone prednisone therapeutic hyd... vincristine sul... allogeneic bone... autologous bone... radiation thera...	15 Years - 60 Years	European Organisation for Research and Treatment of Cancer - EORTC
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery	NCT00002921	Adrenocortical ...	suramin therapeutic hyd...	18 Years -	SWOG Cancer Research Network
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome	NCT00002805	Leukemia	filgrastim cladribine cytarabine etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... autologous bone... peripheral bloo... low-LET cobalt-... low-LET electro... low-LET photon ...	- 21 Years	Children's Oncology Group
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia	NCT00003436	Leukemia Myelodysplastic...	amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone...	- 15 Years	National Cancer Institute (NCI)
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia	NCT00019409	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul... radiation thera...	1 Year - 20 Years	National Institutes of Health Clinical Center (CC)
Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy	NCT00309894	Prostate Cancer	sargramostim ketoconazole therapeutic hyd...	- 120 Years	University of California, San Francisco
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer	NCT00027859	Prostate Cancer	docetaxel estramustine ph... ketoconazole therapeutic hyd...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT00873093	B-cell Adult Ac... B-cell Childhoo... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... T-cell Adult Ac... T-cell Childhoo...	L-asparaginase doxorubicin hyd... therapeutic hyd... vincristine sul... cytarabine prednisone bortezomib pegaspargase methotrexate etoposide phosp... cyclophosphamid... filgrastim leucovorin calc... laboratory biom... High Dose MTX	1 Year - 31 Years	National Cancer Institute (NCI)
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma	NCT00003728	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisolone therapeutic hyd... thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo...	- 17 Years	National Cancer Institute (NCI)
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma	NCT00002552	Lymphoma Multiple Myelom...	filgrastim sargramostim carmustine cyclophosphamid... cytarabine etoposide leucovorin calc... methotrexate perfosfamide therapeutic hyd... allogeneic bone... autologous bone... in vitro-treate... peripheral bloo... syngeneic bone ... radiation thera...	- 70 Years	Barbara Ann Karmanos Cancer Institute
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia	NCT02101853	Recurrent B Acu...	Allogeneic Hema... Asparaginase Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Etoposide Leucovorin Calc... Mercaptopurine Methotrexate Mitoxantrone Mitoxantrone Hy... Pegaspargase Pharmacological... Radiation Thera... Therapeutic Hyd... Thioguanine Vincristine Vincristine Sul...	1 Year - 31 Years	National Cancer Institute (NCI)
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma	NCT00354107	Anaplastic Larg... Recurrent Child...	monoclonal anti... therapeutic hyd... ifosfamide carboplatin etoposide methotrexate cytarabine pharmacological... laboratory biom...	1 Year - 21 Years	National Cancer Institute (NCI)
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00618501	Leukemia	cytarabine daunorubicin hy... etoposide imatinib mesyla... leucovorin calc... methotrexate prednisolone therapeutic hyd... vincristine sul... allogeneic hema...	15 Years -	National Cancer Institute (NCI)
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer	NCT00027859	Prostate Cancer	docetaxel estramustine ph... ketoconazole therapeutic hyd...	18 Years - 120 Years	Eastern Cooperative Oncology Group
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma	NCT00002757	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul...	- 20 Years	Children's Oncology Group
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00618501	Leukemia	cytarabine daunorubicin hy... etoposide imatinib mesyla... leucovorin calc... methotrexate prednisolone therapeutic hyd... vincristine sul... allogeneic hema...	15 Years -	National Cancer Institute (NCI)
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer	NCT00002881	Prostate Cancer	flutamide goserelin aceta... leuprolide acet... suramin therapeutic hyd... orchiectomy	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes	NCT00096135	Leukemia	filgrastim cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine methotrexate pegaspargase therapeutic hyd... vincristine sul... radiation thera...	18 Months - 29 Years	Children's Oncology Group
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer	NCT00006371	Prostate Cancer	aminoglutethimi... ketoconazole therapeutic hyd...	-	H. Lee Moffitt Cancer Center and Research Institute
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome	NCT00002805	Leukemia	filgrastim cladribine cytarabine etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... autologous bone... peripheral bloo... low-LET cobalt-... low-LET electro... low-LET photon ...	- 21 Years	Children's Oncology Group
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma	NCT00003215	Lymphoma	filgrastim CHOP regimen cyclophosphamid... cytarabine doxorubicin hyd... etoposide leucovorin calc... melphalan methotrexate methylprednisol... mitoxantrone hy... prednisone therapeutic hyd... vincristine sul... bone marrow abl... peripheral bloo... radiation thera...	18 Years - 60 Years	Swiss Group for Clinical Cancer Research
High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia	NCT00002865	Leukemia	filgrastim cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mesna methotrexate therapeutic hyd... vincristine sul... low-LET cobalt-... low-LET photon ...	18 Years - 120 Years	Wake Forest University Health Sciences
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia	NCT00550992	Leukemia	anti-thymocyte ... asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide leucovorin calc... melphalan mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisolone prednisone therapeutic hyd... thioguanine vincristine sul... allogeneic bone... allogeneic hema... umbilical cord ...	- 1 Year	Dutch Childhood Oncology Group
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00557193	Acute Lymphobla... Acute Undiffere... Childhood T Acu...	Asparaginase Biospecimen Col... Bone Marrow Bio... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Echocardiograph... Etoposide Filgrastim Laboratory Biom... Lestaurtinib Leucovorin Calc... Mercaptopurine Methotrexate Methylprednisol... Multigated Acqu... Pegaspargase Pharmacological... Prednisone Therapeutic Hyd... Vincristine Sul...	- 1 Year	Children's Oncology Group
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia	NCT00002704	Leukemia	filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ...	- 20 Years	National Cancer Institute (NCI)
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	NCT00049569	L1 Childhood Ac... L2 Childhood Ac... Non-T, Non-B Ch... Recurrent Child... T-cell Childhoo...	cytarabine methotrexate vincristine sul... prednisone pegaspargase doxorubicin hyd... imatinib mesyla... cyclophosphamid... etoposide filgrastim leucovorin calc... asparaginase therapeutic hyd...	1 Year - 21 Years	National Cancer Institute (NCI)
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer	NCT00002760	Prostate Cancer	ketoconazole therapeutic hyd... Withdrawal of a...	- 120 Years	Alliance for Clinical Trials in Oncology
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer	NCT00002881	Prostate Cancer	flutamide goserelin aceta... leuprolide acet... suramin therapeutic hyd... orchiectomy	18 Years -	National Cancer Institute (NCI)
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	NCT03007147	Acute Lymphobla... B Acute Lymphob... Mixed Phenotype... T Acute Lymphob...	Allogeneic Hema... Calaspargase Pe... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Dexrazoxane Hyd... Doxorubicin Etoposide Filgrastim Ifosfamide Imatinib Mesyla... Laboratory Biom... Leucovorin Calc... Mercaptopurine Mercaptopurine Methotrexate Methylprednisol... Pegaspargase Prednisolone Questionnaire A... Therapeutic Hyd... Thioguanine Vincristine Sul...	1 Year - 21 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: